Filings
Finds words inside filing documents. Searching Keros Therapeutics, Inc.'s filings · 69 documents indexed.
6 documents · 11 matches
-
KROS Keros Therapeutics, Inc. 10-Q 2026-11-05
Item 1 · Note 1. Nature of Business and Basis of Presentation
going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of September2 matches in this document -
KROS Keros Therapeutics, Inc. 10-Q 2026-08-03
Item 1 · Note 1. Nature of Business and Basis of Presentation
going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of June2 matches in this document -
KROS Keros Therapeutics, Inc. 10-Q 2026-05-14
Item 1 · Note 1. Nature of Business and Basis of Presentation
going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of March2 matches in this document -
KROS Keros Therapeutics, Inc. 10-K 2026-03-04
Item 16. Form 10-K Summary
going concern for the next 12 months. Management believes that the Company’s $287.4 million cash and cash equivalents as of December1 match in this document -
KROS Keros Therapeutics, Inc. 10-Q 2025-11-05
Item 1 · Note 1. Nature of Business and Basis of Presentation
going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of September2 matches in this document -
KROS Keros Therapeutics, Inc. 10-Q 2025-08-06
Item 1 · Note 1. Nature of Business and Basis of Presentation
going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of June2 matches in this document
Page 1 of 1 · 6 documents